Revvity is pleased to announce our presence at the Medlab Middle East Congress 2024, Dubai, UAE. It gives us great pleasure to invite you to our booth and discuss about our innovations and unique offerings. We hope to see you at the show!
Booth : #Z5.A20Location: Dubai World Trade Centre Sheikh Zayed Rd - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates | Exhibition Opening Hours |
|---|---|
| Monday, February 05-08, 2024 | 10.00 to 18.00 (GST) |
Featured Solutions
Reproductive Health Screening
Explore how, together, we can elevate health outcomes for mothers and babies globally. Our commitment extends beyond our product line, as we strive to empower laboratories, clinicians, and communities worldwide in harnessing the potential of prenatal and newborn screening. Discover our solutions including instrumentation, reagents, and software for early risk assessment in the pregnancy to screening inborn errors of metabolism.
Latent Tuberculosis Infection
The T-SPOT.TB test is a unique, single-visit blood test for tuberculosis designed to reduce assay variability and maximize sensitivity, even in the immunosuppressed. When your test looks for signs of TB infection using T cells, it matters how many T cells you include. The T-SPOT.TB test, unlike other tests, uses the same number each time. 250,000 cells per well, four wells per test. That’s a million witnesses to infection – and a moment of truth for TB.
Reference for UK PI: 1.Oxford Immunotec. T-SPOT.TB Package Insert PI-TB-IVD-UK-v5. Abingdon, UK. November 2023
Genomics Analysis
Our automated solutions are designed to streamline your genomic processes, from sample to solution. Tailored for various applications like SARS-CoV-2 testing, nucleic acid isolation and PCR setup, NGS sample prep, AAV characterization, CRISPR fragment analysis, molecular cytogenetics and protein characterization, and more, our comprehensive workflows ensure a hassle-free laboratory experience. These solutions are designed to eliminate the challenges associated with genomic analysis by providing labs with complete, single source solutions encompassing everything from sample to solution.
Automation and Software Solutions
We provide customized automation and software solutions for diagnostic laboratories of all sizes - tailormade for your needs. Discover our platforms to ensure efficient, convenient and reliable processing as well as evaluation of ELISA, chemiluminescence immunoassays, immunoblots, PCR-based tests as well as indirect immunofluorescence assays for various diagnostic areas.
Specialty Immunoassay Solutions
Visit our booth to discover innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in autoimmunity, infectious diseases and allergy.
United in Science
Revvity and Euroimmun are at the forefront of healthcare innovation, excelling in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and beyond. Leveraging a strong global network and adaptable local capabilities, we cater to a wide array of organizations, spanning pharmaceuticals, biotech, clinical labs, academia, and governments.
About Revvity
Revvity is a pioneering force in health science solutions, offering end-to-end workflows from discovery to development and diagnosis to cure. With specialized focus areas including, translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis and informatics, our global network serves a range of organizations from pharmaceutical and biotech companies to clinical labs, academic institutions, and government bodies.
About EUROIMMUN
EUROIMMUN is a leading global provider of medical laboratory products for autoimmune, infection, allergy and molecular genetic diagnostics and is now a key part of Revvity. Our portfolio encompasses a broad range of detection technologies, such as innovative chemiluminescence immunoassay solutions from IDS as well as ELISA, IFA, and immunoblot, and spans over a thousand diagnostic parameters. State-of-the-art instruments and software provide efficient automation of analyses, increasing productivity and reliability in routine diagnostics.
About IDS
Immunodiagnostic Systems is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture, and market innovative immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.
-
Disclaimer: Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability. The views and opinions expressed herein are those of the presenters and do not necessarily reflect the views of Revvity. The content is provided solely for informational purpose and does not constitute medical advice or intended to be used as healthcare recommendations.
Please note that product labeling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.